(HealthDay News) — American Cancer Society (ACS) guidelines for cervical cancer have been expanded to include self-collection for human papillomavirus (HPV) testing, according to an article published online Dec. 4 in CA: A Cancer Journal for Clinicians.
Rebecca B. Perkins, MD, from Tufts University School of Medicine in Boston, and colleagues expanded the 2020 ACS cervical cancer screening guidelines for average-risk women and individuals with a cervix who are at average risk.
The researchers expanded screening guidelines to include self-collection for HPV testing and revised guidance for exiting screening. The ACS endorses recommendations for self-collected vaginal specimens: clinician-collected cervical specimens are preferred for primary HPV screening, while self-collected specimens are acceptable for average-risk individuals aged 25 to 65 years; repeat screening is recommended 3 years after a negative test for self-collected screening. Clinician-collected samples are still recommended for certain high-risk individuals.
Read Full Article Here
